Cipla
It is estimated that Cipla’s revenue in the third quarter of FY 2021 is expected to grow by 15 per cent year-on-year to Rs 5031.5 crore. 4371 crores in the third quarter of last year. The company’s profit in the third quarter of FY 2021 is expected to increase to Rs 642 crore from Rs 351.02 crore in the third quarter of last year.
It is estimated that the EBITDA of the company is expected to show a 38 per cent growth year-on-year in the third quarter and has increased from Rs 758.3 crore to Rs 1044. At the same time, the margin may increase from 17.3 per cent to 21 per cent.
Sun Pharma
It is estimated that in the third quarter of FY 2021, Sun pharma’s income is expected to grow by 6 per cent year-on-year to Rs 8367 crore. 8155 crores in the third quarter of last year. The company’s profit in the third quarter of FY 2021 is expected to increase to Rs 1334 crore from Rs 913.5 crore in the third quarter of last year.
It is estimated that the EBITDA of the company is expected to show an 18 per cent growth year-on-year in the third quarter and may increase from Rs 1841.4 crore to Rs 2171.2 crore. At the same time, the margin may increase from 22.6 percent to 25 percent.
These 10 stocks are on Brokerage Firms radar for 37 percent upside this year
